BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21108338)

  • 1. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
    Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
    J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
    Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
    Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
    Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
    Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
    J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
    Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
    J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
    Yeh CT; So M; Ng J; Yang HW; Chang ML; Lai MW; Chen TC; Lin CY; Yeh TS; Lee WC
    Hepatology; 2010 Dec; 52(6):1922-33. PubMed ID: 20814897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.
    Yuen MF; Tanaka Y; Mizokami M; Yuen JC; Wong DK; Yuan HJ; Sum SM; Chan AO; Wong BC; Lai CL
    Carcinogenesis; 2004 Sep; 25(9):1593-8. PubMed ID: 15090469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
    Xiao L; Zhou B; Gao H; Ma S; Yang G; Xu M; Abbott WG; Chen J; Sun J; Wang Z; Hou J
    J Med Virol; 2011 Sep; 83(9):1544-50. PubMed ID: 21739444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.
    Dong Q; Chan HL; Liu Z; Chan DP; Zhang B; Chen Y; Kung HF; Sung JJ; He ML
    Biochem Biophys Res Commun; 2008 Oct; 374(4):773-6. PubMed ID: 18675784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.